View Studies By Physician
Investigator
investigator name
phone number
email
bio
biography
View Studies By Condition:
Condition |
Study Title |
Investigator |
Childhood Leukemia |
PEPN2113: Study of Uproleselan in Children with AML, MDS, or MPAL |
Luca Szalontay, MD |
Cancer |
Study of Relatlimab and Nivolumab in Patients Under 30 Years Old with Classical Hodgkin Lymphoma (cHL) and Non-Hodgkin Lymphoma (NHL) |
Nobuko Hijiya, MD |
Lymphoma |
Study of Relatlimab and Nivolumab in Patients Under 30 Years Old with Classical Hodgkin Lymphoma (cHL) and Non-Hodgkin Lymphoma (NHL) |
Nobuko Hijiya, MD |
Leukemia |
Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) |
Luca Szalontay, MD |
Childhood Leukemia |
Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) |
Luca Szalontay, MD |
Cancer |
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors |
Luca Szalontay, MD |
Pediatrics |
ICON3: A Phase 3 Study of Eltrombopag vs. Standard Therapy for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children |
Cindy Neunert, MD |
Childhood Leukemia |
Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 |
Nobuko Hijiya, MD |
Leukemia |
Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 |
Nobuko Hijiya, MD |
Cancer |
A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab |
Luca Szalontay, MD |